Key Points Ford reported a 14.2% jump in Q2 unit sales, driven by pricing incentives to lure in customers. Shares of the ...

Kai Mao, an exterior designer at Dongfeng Design, also doubles in his free time as the virtual artist behind the 'kaiser.mao' ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of $1.

Most automakers’ Q2 sales in the U.S. didn’t fare well, and of the three that did experience gains, one stood out ...

Wall Street futures are trading little changed at this hour in the premarket session on Thursday (July 17). Dow Jones futures ...

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Abbott, a global healthcare leader, has reported strong results for its second quarter of 2025. According to the company's ...

Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...

Abbott (NYSE: ABT) shares dipped before hours today on second-quarter results that came in ahead of the consensus forecast.

General Motors' Hummer EV and Ford's F-150 Lightning beat Tesla's Cybertruck in the US electric pick-up market for Q2 2025.

Revenues from the company's medical devices segment grew 12% in the quarter, fueled by double-digit gains in diabetes care, heart failure, electrophysiology, and rhythm management, with continuous ...

Lucid, which has always offered an array of driver-assistance features, is now expanding the suite of driver aids on its ...